Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis

Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis

Bibliographic Details
Main Authors:	Brandt, Claudia, Thronicke, Anja, Roehmel, Jobst F., Krannich, Alexander, Staab, Doris, Schwarz, Carsten
Format:	Online
Language:	English
Published:	Public Library of Science 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924629/

Similar Items

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
by: Roehmel, Jobst, et al.
Published: (2014)

Inhibition of granulocyte migration by tiotropium bromide
by: Vacca, Gabriela, et al.
Published: (2011)

The evidence on tiotropium bromide in asthma: from the rationale to the bedside
by: Dejan Radovanovic, et al.
Published: (2017-05-01)

Hemoglobin Oxygen Affinity in Patients with Cystic Fibrosis
by: Böning, Dieter, et al.
Published: (2014)

Skin reaction to inhaled tiotropium bromide: a case report
by: Incorvaia, Cristoforo, et al.
Published: (2011)

Suppression of IL-8 production from airway cells by tiotropium bromide in vitro
by: Suzaki, Isao, et al.
Published: (2011)

Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
by: Dejan Radovanovic, et al.
Published: (2017-06-01)

Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
by: Algorta, Jaime, et al.
Published: (2016)

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
by: Alvarado-Gonzalez, Alcibey, et al.
Published: (2015)

Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate
by: Hanna, Mariam, et al.
Published: (2014)

Staff costs of hospital-based outpatient care of patients with cystic fibrosis
by: Hollmeyer, Helge, et al.
Published: (2011)

Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy
by: Papayannopoulos, Venizelos, et al.
Published: (2011)

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results
by: Bradley, Judy M., et al.
Published: (2014)

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
by: Trudo, Frank, et al.
Published: (2015)

Efficacy of Tiotropium Bromide and Rehabilitation Treatment on Pulmonary Function of Patients With Sulfur Mustard Lung Injury
by: Shohrati, Majid, et al.
Published: (2015)

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
by: Price, David, et al.
Published: (2015)

Tiotropium in asthma: a systematic review
by: Befekadu, Elizabeth, et al.
Published: (2014)

Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease
by: Hohlfeld, JM, et al.
Published: (2014)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
by: Scheuing, Nicole, et al.
Published: (2013)

Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis
by: Dorkin, Henry L, et al.
Published: (2015)

The role of tiotropium in the management of asthma
by: Park, Heung-Woo
Published: (2012)

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
by: Vázquez-Espinosa, Emma, et al.
Published: (2015)

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
by: Nicolini, Antonello
Published: (2012)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin, David A, et al.
Published: (2013)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt, Béla Z, et al.
Published: (2016)

Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function
by: Paganin, Patrizia, et al.
Published: (2015)

Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
by: Bacci, Giovanni, et al.
Published: (2016)

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
by: Bacci, Giovanni, et al.
Published: (2016)

A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product
by: Trivedi, Rakshit Kanubhai, et al.
Published: (2012)

Clinical efficacy of tiotropium in children with asthma
by: Huang, Juan, et al.
Published: (2016)

Microalbuminuria in Patients With Cystic Fibrosis
by: Lind-Ayres, Melanie, et al.
Published: (2011)

The role of the UPS in cystic fibrosis
by: Turnbull, Emma L, et al.
Published: (2007)

Sinonasal Manifestations in Cystic Fibrosis
by: Oomen, Karin P. Q., et al.
Published: (2012)

Calprotectin in Cystic Fibrosis
by: Rumman, Nisreen, et al.
Published: (2014)

Nontuberculous Mycobacteria in Cystic Fibrosis
by: Skolnik, Kate, et al.
Published: (2016)

Porosome in Cystic Fibrosis
by: Jena, Bhanu P.
Published: (2014)

Liver disease in cystic fibrosis
by: Kobelska-Dubiel, Natalia, et al.
Published: (2014)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R Andres, et al.
Published: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
by: Floto, R Andres, et al.
Published: (2016)